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INTRODUCTION 
Topical gel preparation has remains one of the most popular 
and important pharmaceutical dosage forms. As a result, the 
therapeutics effects of the drugs are achieved effectively 
whereas the systemic side effects can be avoided or 
minimized. The Non-Steroidal Anti-Inflammatory Drugs 
(NSAIDs) have been widely used in the treatment of 
rheumatoid arthritis and other related condition .However, 
they carry the risk of undesirable systemic side effect and 
gastrointestinal irritation at the usual dose of oral 
administration1 .Considering the fact that most inflammatory 
diseases occur locally and near the surface of the body 
,topical application of NSAID on the inflamed site can offer 
the advantage of delivering a drug directly to the disease site 
and producing its local effect .This occurs by avoiding 
gastric irritation and also reduced adverse systemic effect2,3 
.However the barrier properties of intact skin limit the 
permeability of wide variety of substance including 
pharmaceutical active agent. Aceclofenac is largely based on 
the inhibition of prostaglandin synthesis. It is potent inhibitor 
of the enzyme cyclooxygenase, which is involved in the 
production of prostaglandins and has analgesic and anti-
inflammatory activity, widely used in the treatment of 
rheumatoid arthritis, osteoarthritis and other joint disease. 
Aceclofenac was similar to that comparator NSAID in 
individual clinical trial withdrawal rate due to these events 
were significantly lower Aceclofenac than with Ketoprofen 
and Temoxicam.Other adverse effects which are not common 
such as dizziness (1%), vertigo (0.3%) and tremor4, 5. The 
objective of present study was conducted to develop a gel 
formulation of aceclofenac using four types of gelling agents: 
carbopol-934, carbopol-940 hydroxypropylmethylcellulose 
(HPMC) and poloxamer-407. Effect of penetration enhancer 
(propylene glycol) on the release has been studied. The gels 
were evaluated for physical appearance, rheological 
behavior, drug release and stability. The drug release from all 
gelling agents through standard cellophane membrane was 
evaluated using Franz diffusion cell. 
MATERIALS AND METHODS 
Aceclofenac (Mecleods pharmaceutical, Baddi), 
Carbopol‐934 and Carbopol‐940 (ultratech pharmaceutical 
Baddi), Poloxamer 407 (Signet Chemicals), HPMC 
(Qualikem chemicals,Delhi) Propylene glycol (S.D Fine 
chemical, Mumbai) and other ingredients used were of 
analytical grade. 
Preparation of carbopol & HPMC gel 
Required amount of Aceclofenac was dissolved in solvent 
mixture and then the required quantity of polymer was added 
to the solution with constant stirring at 500 rpm for about 2 
hours. Later the speed was reduced to avoid air entrapment. 
Then the solution was neutralized with triethanolamine. 
Preparation of poloxamer gel 
The gels were prepared by modification of the “Cold 
dispersion” method described by Schmolka. The weighed 
amount of drug and poloxamer were placed in beaker and left 
in an oven at 1100C for 15 minutes to obtain a homogeneous 
liquefied mixture. After the solution was cooled to room 
temperature, the other ingredient was added with continuous 
agitation. The beaker was left in a refrigerator until a clear 
solution was obtained. The gel was formed when the solution 
was brought back to room temperature and stored at ambient 
temperature prior use. 
 
 
 
 
ABSTRACT 
Topical gel formulations of Aceclofenac were prepared using these polymers such as Carbopol‐934, Carbopol‐940, HPMC, 
Poloxamer 407 in different concentration for the treatment of rheumatoid arthritis. The gels were evaluated for various 
parameters such as homogeneity, grittiness, skin irritancy, extrudability, in vitro drug release, viscosity(Brooke field 
viscometer), pH, drug content, stability studies. The in vitro release rate of gel was evaluated using Franz diffusion cell 
containing cellophane membrane with phosphate buffer pH 7.4 as the receptor medium. The release rate of the gel was found 
to obey Higuchi model. The percentage of drug release follow following order Poloxamer-407> HPMC> Carbopol-
940>Carbopol-934. 
Keywords: Aceclofenac, carbopol, poloxamer hydroxyl propyl methyl cellulose, anti inflammatory activity. 
Guleri et al                                          Journal of Drug Delivery & Therapeutics; 2013, 3(6), 51-53     52 
© 2011, JDDT. All Rights Reserved                                                       ISSN: 2250-1177                                                      CODEN (USA): JDDTAO 
Table 1: Different gel formulations 
S.N. Ingredients 
(%w/w) 
 Formulation Code 
F1 F2 F3 F4 F5 F6 F7 F8 F9 F10 F11 F12 F13 F14 F15 F16 
1 Aceclofenac 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
2 Carbopol-934 0. 5 1.0 1.5 2.0 - - - - - - - - - - - - 
3 Carbopol-940 - - - - 0.5 1.0 1.5 2.0 - - - - - - - - 
4 HPMC - - - - - - - - 2.0 4.0 6.0 8.0 - - - - 
5 Poloxamer-407 - - - - - - - - - - - - 15 20 25 30 
6 Propylene 
Glycol 
15 15 15 15 15 15 15 15 15 15 15 15 15 15 15 15 
7 Triethanolamine 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 
8 Acetone 30 30 30 30 30 30 30 30 30 30 30 30 30 30 30 30 
9 Propyl paraben 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 
10 Water up to q.s q.s q.s q.s q.s q.s q.s q.s q.s q.s q.s q.s q.s q.s q.s q.s 
 
Evaluation 
Following parameters were used for the evaluation of gels: 
Homogeneity 
All developed gels were tested for homogeneity by visual 
inspection after the gels have been set in the container. They 
were tested for their appearance and presence of any 
aggregates. 
Grittiness 
All the formulations were evaluated microscopically for the 
presence of particles if any no appreciable particulate matter 
was seen under light microscope. Hence obviously the gel 
preparation fulfils the requirement of freedom from 
particular matter and from grittiness as desired for any 
topical preparation. 
Extrudability study 
A good gel extrude optimally from the gel with slight 
pressure applied. The extrudability of formulations from 
aluminium collapsible tubes was determined using universal 
tube filling machine. Aluminium collapsible tubes filled with 
10g gels were held between two clamps. A tube was 
compressed and extrudibility of the formulation was 
determined in terms of weight in grams required to extrude a 
0.5 cm. ribbon of gel in 10 seconds6. 
Measurement of pH 
The pH of Aceclofenac gel formulations was determined by 
using digital pH meter. One gram of gel was dissolved in 100 
ml of distilled water and stored for two hours. The 
measurement of pH of each formulation was done in 
triplicate and average values were calculated. 
Drug content 
A 500 mg of Aceclofenac gel was taken and dissolved in 50 
ml of phosphate buffer pH 7.4.The volumetric flask were 
kept for 2 hours and shaken well in a shaker to mix it 
properly. The solution was passed through the filter paper 
and filtered. The drug content was measured 
spectrophotometrically at 276 nm against corresponding gel 
concentration as blanks7. 
Viscosity study 
The measurement of viscosity of the prepared gel was done 
with a Brookfield Viscometer. The gels were rotated at 20 
and 30 rpm using spindle no. 64. At each speed, the 
corresponding dial reading was noted. 
Invitro diffusion studies 
The in vitro diffusion studies of prepared gel were carried out 
in Franz diffusion cell using through a cellophane 
membrane.100 ml of phosphate buffer was used as receptor 
compartment, then 500 mg of gel containing 10 mg of 
Aceclofenac was spread uniformly on the membrane. The 
donor compartment was kept in contact with a receptor 
compartment and the temperature was maintained at 
37±0.50. The solution on the receptor side were stirred by 
externally driven Teflon coated magnetic bars at 
predetermined time intervals, pipette out 5ml of solution 
from the receptor compartment and immediately replaced 
with the fresh 5ml phosphate buffer. The drug concentration 
on the receptor fluid was determined spectrophotometrically 
against appropriate blank. The experiment was carried out in 
triplicate8. 
Stability study 
For the evaluation of stability study, maintaining the 
formulations at an ambient condition over a period of three 
months on temperature 40c, 250c, and 370c. The physical 
appearance, Homogenicity, viscosity was determined 
periodically9.
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Evaluation data 
Table 2: Evaluation data of Aceclofenac gels 
Excellent ***, Good **, Satisfactory *, No grittiness & skin irritation‐ 
 
 
Figure 1: In vitro release of Aceclofenac from different 
gel formulations through Cellophane Membrane 
RESULT AND DISCUSSION 
From the experimental work finding it can be concluded that 
Aceclofenac is a non-steroidal anti-inflammatory drug (NSAID) 
that exhibits anti-inflammatory, analgesic activities and used for 
the treatment of rheumatoid arthritis. Aceclofenac by oral 
administration can produces stomach indigestion, so it is not 
suitable for the treatment of rheumatoid arthritis patient with 
gastric ulcer, so, to avoid gastric irritation to G.I.T, minimizing 
systemic toxicity. To overcome the side effects associated with 
oral aceclofenac therapy and to have the benefits associated with 
topical therapy; Aceclofenac topical gels are prepared in this 
study. Studies showed that drug release was decrease with 
increase in gelling agent concentration because polymer 
concentration increases; viscosity increases. The best release 
pattern of drug was observed F15- Poloxamer-407. 
So, then release pattern order is Poloxamer-407> 
HPMC>Carbopol-940> Carbopol-934  
On the basis of physical parameters and release pattern F2, F6, 
F11, F15 selected as best formulations. Further stability of 
selected formulation had been done on different temperature 
such as on 4°c, 25°c and 37°c for 3 months. There were no 
significant changes in the viscosity, and physical appearance of 
the gel after storing at different temperature conditions for three 
months.
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GRAPH  B/W CUMULATIVE % DRUG 
PERMEATED V/S TIME  
F2 
F6
F11
F15
Formulation 
code 
Homogeneity Grittiness Extrudability Skin 
irritation 
pH Viscosity 
cps± S.E 
Drug content 
(%)±SE 
FI ** -- ** -- 6.33+0.48 16425.64±17.55 89.54±2.0 
F2 ** -- ** -- 6.42+0.39 1763.33±7.65 90.10±3.2 
F3 *** -- *** -- 7.21+0.26 18534.45±10.44 93.32±1.6 
F4 ** -- ** -- 6.72+0.14 18734.31±15.28 90.62±1.5 
F5 *** -- *** -- 6.81+0.32 17341.62±20.21 91.12±2.4 
F6 ** -- ** -- 6.52+0.35 1852.61±12.58 91.54±4.3 
F7 *** -- *** -- 7.26+0.41 19712.63±7.61 95.36±4.7 
F8 ** -- ** -- 6.67+0.13 1996.32±10.41 89.62±5.1 
F9 ** -- ** -- 6.46+0.15 9918.71±16.81 92.08±4.9 
F10 *** -- *** -- 6.41+0.17 9551.91±15.14 87.14±2.5 
F11 *** -- *** -- 6.68+0.11 1025.21±13.43 96.22±2.2 
F12 ** -- ** -- 6.61+0.24 1121.66±11.92           89.22±2.3 
F13 *** -- *** -- 6.85+0.21 7866.67±7.62 94.67±4.2 
F14 ** -- ** -- 6.87+0.31 9943.11±11.37 93.55±3.8 
F15 *** -- *** -- 7.12+0.16 8931.30±10.49 99.51±3.7 
F16 *** -- *** -- 6.75+0.33 11226.28±11.25 98.60±1.6 
